期刊
BRITISH JOURNAL OF CANCER
卷 101, 期 8, 页码 1316-1320出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6605314
关键词
bladder cancer; transitional cell urothelial carcinoma; glucocorticoids; immunosuppressive therapy; case-control study
类别
资金
- National Institute of Environmental Health Sciences, NIH [5 P42 ES007373]
- National Cancer Institute, NIH [CA57494]
BACKGROUND: Use of immunosuppressive drugs post organ transplantation, and prolonged use of glucorticoids for other conditions have been associated with subsequent risk of certain malignancies, that is, skin cancers and lymphoma. There is evidence that the incidence of bladder cancer is also elevated among organ transplant recipients, however, it is unknown whether other groups of patients, that is, those taking oral glucocorticoids, likewise are at an increased risk. METHODS: In a population-based case-control study in New Hampshire, USA, we compared the use of glucocorticoids in 786 bladder cancer cases and in 1083 controls. We used unconditional logistic regression analysis to compute adjusted odds ratios (ORs) associated with oral glucocorticoid use. RESULTS: In our analysis, the risk of bladder cancer was related to a history of prolonged oral glucocorticoid use (OR = 1.85, 95% CI = 1.24-2.76, adjusted for age, gender and smoking). Associations with oral glucocorticoid use were stronger for invasive tumours (OR = 2.12, 95% CI = 1.17-3.85) and tumours with high (3 +) p53 staining intensity (OR = 2.35, 95% CI = 1.26-4.36). CONCLUSION: Our results raise the possibility of an increased risk of bladder cancer from systemic use of glucocorticoids, and a potential role of immune surveillance in bladder cancer aetiology. British Journal of Cancer (2009) 101, 1316-1320. doi:10.1038/sj.bjc.6605314 www.bjcancer.com Published online 22 September 2009 (C) 2009 Cancer Research UK
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据